HEERLEN, Netherlands, Nov. 6, 2013 (GLOBE NEWSWIRE) --
Royal DSM, the global Life Sciences and Materials Sciences company, has
successfully issued a €300 million 1.75% bond due 2019.
The proceeds will be used to refinance the $150 million US Private Placement
that matured in October 2013 and to refinance some short term commercial paper
with a longer maturity.
The terms are laid down in the EUR 4 billion Debt Issuance Program of Royal DSM,
the final terms and the supplements thereto, which are available on the Investor
Relations website.
The re-offer price was 99.96%. Based on this price the yield is 1.7570%. The
bond will be listed on Euronext Amsterdam shortly.
This release does not constitute an offer or an invitation to subscribe for or
purchase any securities. The notes are being offered only by means of a
prospectus.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around €9 billion. The company is
listed on NYSE Euronext. More information can be found www.dsm.com.
Or find us on:
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
e-mail media.relations@dsm.com e-mail investor.relations@dsm.com
Press release-pdf: http://hugin.info/130663/R/1741086/584832.pdf
[HUG#1741086]
